David Abrams - Abrams Capital Management 13F Activity & Position Changes (Q3 2013)

According to the SEC 13F filed on Aug 13, 2026, the Abrams Capital Management portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2013. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2013, the filing reported:

New Buys - None reported

Increases - None reported

Reductions - SLM Corporation

Complete Exits - Assurant, Inc., Teva Pharmaceutical Industries

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q3 2013	AIZ Assurant, Inc.	Assurant, Inc.	Sell - Position Exit	-1,500,000	-100.0%	$0.00	-
Q3 2013	SLM SLM Corporation	SLM Corporation	Sell	-5,082,954	-33.3%	$253.13K	10,165,910
Q3 2013	TEVA Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	Sell - Position Exit	-2,561,269	-100.0%	$0.00	-